Noonberg Sarah B. is a director of Marinus Pharmaceuticals Inc.
Person profile
Roles
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Metagenomi, Inc.
3 Apr 24
3
Metagenomi, Inc.
8 Feb 24
4
MARINUS PHARMACEUTICALS, INC.
19 Jan 24
4
Neurogene Inc.
18 Jan 24
4
Neoleukin Therapeutics, Inc.
9 Jun 23
4
MARINUS PHARMACEUTICALS, INC.
17 May 23
3
MARINUS PHARMACEUTICALS, INC.
17 May 23
4
Protagonist Therapeutics, Inc
18 Jan 23
4
Protagonist Therapeutics, Inc
27 May 22
4
Neoleukin Therapeutics, Inc.
16 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | MGX Metagenomi | Common Stock | Grant | Acquire A | No | No | 0 | 57,763 | 0.00 | 100,374 |
1 Apr 24 | MGX Metagenomi | Stock Option Common Stock | Grant | Acquire A | No | No | 10.82 | 242,875 | 2.63 mm | 242,875 |
18 Jan 24 | MRNS Marinus Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 4,600 | 0.00 | 11,800 |
18 Jan 24 | MRNS Marinus Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 9.74 | 20,900 | 203.57 k | 20,900 |
16 Jan 24 | NGNE Neurogene | Stock Option Common Stock | Grant | Acquire A | No | No | 32.3 | 15,400 | 497.42 k | 15,400 |
8 Jun 23 | NGNE Neurogene | Stock Option Common Stock | Grant | Acquire A | No | No | 0.79 | 25,000 | 19.75 k | 25,000 |